Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PF-05190457 for Alcoholism Treatment
NCT02707055Phase 2Terminated
- Sponsor
- National Institute on Alcohol Abuse and Alcoholism
- Start
- Jun 2016
- Primary completion
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of PF-05190457 in alcohol use disorder (AUD) (2 arms), sponsored by National Institute on Alcohol Abuse and Alcoholism. Primary endpoint: Alcohol Cue-elicited Craving Assessed in a 'Bar-like' Laboratory at 96 minutes. Started Jun 2016; status: terminated.
02
Drugs
PF-05190457
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT02707055.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02707055.